Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp > focusing on c/y run rate is rather stupid

<< Previous

Bullboard Posts

Next >>

Comment by ol_grizon Dec 23, 2022 11:11am

107 Views

Post# 35189485

RE:RE:RE:focusing on c/y run rate is rather stupid

This is a particularly desperate attempt. Bashers in overdrive today.

Carlito3311 wrote: The company explicity gave guidance multiple times and hasn't met it. Further, the debt agreement explicity states that the company cannot do a deal larger than $25 million and no more than $75 million in total deals over the term of the debt agreement (2027). That is right in the agreement. So they cannot give big guidance because the banks now have say over capital allocation.

lscfa wrote:
gibbonsj wrote: It's really a pie in the sky metric when compared to the many beats and accomplishments the company had over the fiscal year. I think it needs to be said that the company progressed from a going concern caveat to sustainable profit. That's a huge milestone accomplished. If the acquisitions needed to bring us to the 200 mil mark don't close before the end of the year it does not take away from the company's performance and accelerating profitability. That's the ball we need to keep your eyes on.

No guidance is required from co. The $110 million credit facility indicates how much more to expect in revenues over the next year or so. $110 million will buy up to $150 million in additional revenues.